Eflucimibe

• Description :

  Eflucimibe (L0081) is an acyl coenzyme A: cholesterol acyltransferase inhibitor for the treatment of cardiovascular disease and endocrine and metabolic disorders, and can be used to study atherosclerosis and hyperlipidemia.

• CAS Number :

  202340-45-2

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  469.72

• Molecular Formula :

  C29H43NO2S

• Notes :

  Research use only, not for human use.

• Receptor :

  Acyltransferase